115 related articles for article (PubMed ID: 3416900)
1. Biological and clinical relevance of Kd values for estradiol binding in primary breast cancer tumors.
Thorpe SM; Rose C
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1163-70. PubMed ID: 3416900
[TBL] [Abstract][Full Text] [Related]
2. Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level.
Drafta D; Prişcu A; Neacşu E; Gangură M; Schindler AE; Stroe E; Anghel C; Panaitescu G
J Steroid Biochem; 1983 Apr; 18(4):459-63. PubMed ID: 6834830
[TBL] [Abstract][Full Text] [Related]
3. Estradiol and progesterone binding in uterine leiomyomata and pregnant myometrium.
Nardelli GB; Mega M; Bertasi M; Siliotti F
Clin Exp Obstet Gynecol; 1987; 14(3-4):155-60. PubMed ID: 3454723
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with toremifene.
Valavaara R; Tuominen J; Johansson R
Cancer; 1990 Dec; 66(11):2264-9. PubMed ID: 2147123
[TBL] [Abstract][Full Text] [Related]
7. Decrease in estradiol-stimulated progesterone receptor production in MCF-7 cells by epidermal growth factor and possible clinical implication for paracrine-regulated breast cancer growth.
Cormier EM; Wolf MF; Jordan VC
Cancer Res; 1989 Feb; 49(3):576-80. PubMed ID: 2783381
[TBL] [Abstract][Full Text] [Related]
8. Estrogen control of lactate dehydrogenase isoenzyme-5 in human breast cancer.
Nagai MA; Sonohara S; Brentani MM
Int J Cancer; 1988 Jan; 41(1):10-6. PubMed ID: 2826342
[TBL] [Abstract][Full Text] [Related]
9. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and progesterone receptor profile patterns in primary breast cancer.
Thorpe SM; Rose C; Pedersen BV; Rasmussen BB
Breast Cancer Res Treat; 1983; 3(1):103-10. PubMed ID: 6871479
[TBL] [Abstract][Full Text] [Related]
11. Hormonal receptor determination of 1,052 Chinese breast cancers.
Chow LW; Ho P
J Surg Oncol; 2000 Nov; 75(3):172-5. PubMed ID: 11088048
[TBL] [Abstract][Full Text] [Related]
12. Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.
Paradiso A; Tommasi S; Mangia A; Lorusso V; Simone G; De Lena M
Cancer Res; 1990 May; 50(10):2958-62. PubMed ID: 2334898
[TBL] [Abstract][Full Text] [Related]
13. [Infiltrating duct breast carcinoma: the role of estradiol and progesterone receptors].
Salazar Esquivel EL; Morales Nájar R; Calzada Sánchez L
Ginecol Obstet Mex; 1994 Mar; 62():85-90. PubMed ID: 8168725
[TBL] [Abstract][Full Text] [Related]
14. Correlation between prolactin receptors (PRL R), estradiol (ER) and progesterone receptors (PgR) in human breast cancer.
Bonneterre J; Peyrat JP; Beuscart R; Demaille A
Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1331-6. PubMed ID: 3830215
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
Macías A; Pascual MR; Pérez R; Lage A
Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.
Alexieva-Figusch J; Van Putten WL; Blankenstein MA; Blonk-Van Der Wijst J; Klijn JG
Cancer; 1988 Feb; 61(4):758-68. PubMed ID: 3338038
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic estrogen and progesterone receptors in canine endometrium during the estrous cycle.
Johnston SD; Kiang DT; Seguin BE; Hegstad RL
Am J Vet Res; 1985 Aug; 46(8):1653-8. PubMed ID: 4041148
[TBL] [Abstract][Full Text] [Related]
19. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
20. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
